scholarly journals Effect of hyperthermic intrathoracic chemotherapy on the malignant pleural mesothelioma: a systematic review and meta-analysis

Oncotarget ◽  
2017 ◽  
Vol 8 (59) ◽  
pp. 100640-100647 ◽  
Author(s):  
Zi-Yi Zhao ◽  
Sha-Sha Zhao ◽  
Meng Ren ◽  
Zi-Ling Liu ◽  
Zhi Li ◽  
...  
Keyword(s):  
Systematic Review ◽  
Malignant Pleural Mesothelioma ◽  
Meta Analysis ◽  
Pleural Mesothelioma

scholarly journals Diagnostic value of fibulin-3 for malignant pleural mesothelioma: A systematic review and meta-analysis

Oncotarget ◽  
2016 ◽  
Vol 7 (51) ◽  
pp. 84851-84859 ◽  
Author(s):  
Ran Ren ◽  
Pengpeng Yin ◽  
Yan Zhang ◽  
Jianyun Zhou ◽  
Yixing Zhou ◽  
...  
Keyword(s):  
Systematic Review ◽  
Malignant Pleural Mesothelioma ◽  
Meta Analysis ◽  
Diagnostic Value ◽  
Pleural Mesothelioma

Diagnostic accuracy of osteopontin for malignant pleural mesothelioma: A systematic review and meta-analysis

2014 ◽  
Vol 433 ◽  
pp. 44-48 ◽  
Author(s):  
Zhi-De Hu ◽  
Xiao-Fei Liu ◽  
Xiao-Cui Liu ◽  
Chun-Mei Ding ◽  
Cheng-Jin Hu
Keyword(s):  
Systematic Review ◽  
Diagnostic Accuracy ◽  
Malignant Pleural Mesothelioma ◽  
Meta Analysis ◽  
Pleural Mesothelioma

scholarly journals Diagnostic accuracy of circulating miR-126 for malignant pleural mesothelioma: a systematic review and meta-analysis

2021 ◽  
Vol 10 (4) ◽  
pp. 1856-1862
Author(s):  
Lei Zhang ◽  
Qianghua Zhou ◽  
Yan-Qiu Han ◽  
Peng Li ◽  
Pei-Heng Ouyang ◽  
...  
Keyword(s):  
Systematic Review ◽  
Diagnostic Accuracy ◽  
Malignant Pleural Mesothelioma ◽  
Meta Analysis ◽  
Pleural Mesothelioma

A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma

Lung Cancer ◽  
2014 ◽  
Vol 83 (2) ◽  
pp. 240-245 ◽  
Author(s):  
Christopher Cao ◽  
David Tian ◽  
John Park ◽  
James Allan ◽  
Kristopher A. Pataky ◽  
...  
Keyword(s):  
Systematic Review ◽  
Malignant Pleural Mesothelioma ◽  
Meta Analysis ◽  
Pleural Mesothelioma ◽  
Surgical Treatments

scholarly journals Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis

2021 ◽  
Vol 30 (162) ◽  
pp. 210057
Author(s):  
Eline Schillebeeckx ◽  
Jan P. van Meerbeeck ◽  
Kevin Lamote
Keyword(s):  
Systematic Review ◽  
Malignant Pleural Mesothelioma ◽  
Early Stage ◽  
Meta Analysis ◽  
External Validation ◽  
Future Research ◽  
Pleural Mesothelioma ◽  
Clinical Implementation ◽  
Diagnostic Biomarkers ◽  
Non Invasive

Malignant pleural mesothelioma (MPM) is characterised by late-stage diagnosis and poor prognosis. Currently, no screening tool is advocated and diagnosis is based on invasive techniques, which are not well tolerated. Non-invasive diagnostic biomarkers have shown potential and could have a huge clinical benefit. However, despite extensive research, there is no consensus yet on their clinical use, with many articles reporting contradicting results, limiting their clinical implementation. The aim of this systematic review is therefore to explore the different semi- and non-invasive diagnostic markers in several human matrices and identify those that might clinically be relevant. A total of 100 articles were selected through Web of Science and PubMed, with 56 articles included in the quantitative analysis. Although many studies have reported on the diagnostic accuracy of MPM biomarkers such as serum mesothelin and high-mobility group box protein 1 and plasma fibulin-3, none have resulted in a validated test for early detection. Future research should focus on external validation, combinations into biomarker panels, the inclusion of early stage MPM patients and a combination of different biomarker matrices, as well as new markers.

Sign in / Sign up

Export Citation Format

Share Document